Table 3.
Characteristics | Bivariable Regression | Multivariable Regression | ||
---|---|---|---|---|
Odds Ratio (95% CI) | P-value | Adjusted Odds Ratio (95% CI) | P-value | |
Opioid agonist therapy, among: | ||||
High frequency user | 0.57 (0.34, 0.95) | 0.031 | 0.36 (0.20, 0.63) | <0.001 |
Gradually increasing frequency user | 1.35 (0.85, 2.14) | 0.203 | 0.91 (0.53, 1.56) | 0.735 |
Gradually increasing frequency user vs. High frequency user, when: | ||||
Not on opioid agonist therapy | 0.23 (0.11, 0.46) | <0.001 | 0.23 (0.11, 0.49) | <0.001 |
On opioid agonist therapy | 0.54 (0.33, 0.88) | 0.014 | 0.59 (0.36, 0.99) | 0.047 |
Sociodemographic factors | ||||
Age, per year increase | 0.96 (0.94, 0.98) | <0.001 | 0.97 (0.94, 1.00) | 0.030 |
Male | 1.27 (0.77, 2.08) | 0.349 | ||
White ethnicity | 0.81 (0.50, 1.30) | 0.378 | ||
Being in a stable relationship a | 1.00 (0.69, 1.45) | 0.983 | ||
Employment status (regular/temporary job; self-employed) a | 1.15 (0.80, 1.66) | 0.448 | ||
Unstable housing | 2.33 (1.66, 3.26) | <0.001 | 1.56 (1.09, 2.24) | 0.015 |
Substance use a | ||||
Any stimulant use | 5.16 (3.59, 7.41) | <0.001 | 3.69 (2.52, 5.39) | <0.001 |
Cannabis use | 1.64 (1.18, 2.28) | 0.003 | 1.32 (0.93, 1.87) | 0.119 |
Daily alcohol | 0.76 (0.39, 1.45) | 0.400 | ||
Benzodiazepine use | 1.67 (0.71, 3.96) | 0.241 | ||
Treatment experience | ||||
Any opioid agonist therapy before study enrollment | 1.21 (0.73, 2.02) | 0.451 | ||
Any other addiction treatment or services a | 0.50 (0.28, 0.91) | 0.023 | 0.47 (0.23, 0.97) | 0.040 |
Behavioural risk factors a | ||||
Attacked, assaulted, or suffered violence | 2.31 (1.48, 3.61) | <0.001 | 1.64 (1.02, 2.65) | 0.041 |
Drug dealing | 5.20 (3.47, 7.77) | <0.001 | 3.30 (2.17, 5.02) | <0.001 |
Sex work involvement | 5.23 (2.59, 10.54) | <0.001 | 2.75 (1.31, 5.78) | 0.008 |
Incarceration | 3.22 (1.95, 5.33) | <0.001 | 2.24 (1.31, 3.83) | 0.003 |
Other factors | ||||
Study cohort designation (ACCESS) | 0.62 (0.35, 1.08) | 0.091 | 0.75 (0.43, 1.32) | 0.322 |
Study cohort designation (ARYS) | 1.32 (0.74, 2.33) | 0.347 | 0.92 (0.42, 2.03) | 0.837 |
Calendar year on opioid agonist therapy | 0.97 (0.91, 1.03) | 0.327 |
ACCESS AIDS Care Cohort to evaluate Exposure to Survival Services; AYRS At-Risk Youth Study; CI confidence interval.
Denotes behaviours and events in the previous six months.